Prospera Financial Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $552K | Buy |
|
|||||
|
2025
Q3 | $541K | Buy |
|
|||||
|
2025
Q2 | $482K | Buy |
|
|||||
|
2025
Q1 | $296K | Buy |
|
|||||
|
2024
Q4 | $354K | Buy |
|
|||||
|
2024
Q3 | $297K | Sell |
|
|||||
|
2024
Q2 | $359K | Sell |
|
|||||
|
2024
Q1 | $405K | Buy |
|
|||||
|
2023
Q4 | $374K | Sell |
|
|||||
|
2023
Q3 | $329K | Sell |
|
|||||
|
2023
Q2 | $283K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $46K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.23M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1K | Buy |
|